Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Organogenesis Holdings Inc. (NASDAQ: ORGO)
ORGO Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
20.20%
Analyst Rating:
BUY
Analyst Forecast (1yr):
43.10%
ORGO Stock Analysis
ORGO
PE Ratio:
ORGO
PEG Ratio:
Not Available
ORGO
Forward EPS Growth (12 month):
0.00%
ORGO
PS Ratio:
0.6
ORGO
PSG Ratio:
ORGO
Forward Revenue Growth (12 month):
26.30%
ORGO Articles
No data was found